{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:41:11Z","timestamp":1790336471631,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.cbi.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T14:51:58Z","timestamp":1362408718000},"page":"530-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Oral l-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin\u2013nicotinamide induced diabetic rats"],"prefix":"10.1016","volume":"203","author":[{"given":"Sachin L.","family":"Badole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita P.","family":"Bagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar P.","family":"Mahamuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha D.","family":"Khose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja C.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh B.","family":"Jangam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvindkumar E.","family":"Ghule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekhar G.","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay M.","family":"Khedkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evans C.","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2013.02.006_b0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.physbeh.2011.12.001","article-title":"Nutrient detection by incretin hormone secreting cells","volume":"106","author":"Diakogiannaki","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.cbi.2013.02.006_b0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2009.06.002","article-title":"Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors","volume":"124","author":"Verspohl","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.cbi.2013.02.006_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/dmrr.538","article-title":"Glucagon-like peptide-1(GLP-1) in biology and pathology","volume":"21","author":"Meier","year":"2005","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"10","key":"10.1016\/j.cbi.2013.02.006_b0020","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1093\/jn\/138.10.2025S","article-title":"Nonnutritive effects of glutamine","volume":"138","author":"Roth","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.cbi.2013.02.006_b0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0210-5691(07)74845-3","article-title":"l-glutamine, un aminoa\u00b4cido casi indispensable en elenfermo cr\u0131\u00b4tico","volume":"31","author":"Bonet","year":"2007","journal-title":"Med. Intensiva"},{"key":"10.1016\/j.cbi.2013.02.006_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/db06-S006","article-title":"Amino acid metabolism, \u03b2-cell function and diabetes","volume":"55","author":"Newsholme","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2013.02.006_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.regpep.2009.08.001","article-title":"Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes","volume":"160","author":"Menge","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.cbi.2013.02.006_b0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jn\/126.1.273","article-title":"l-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in c57bl\/6j mice 1\u20322\u20323","volume":"126","author":"Opara","year":"1996","journal-title":"J. Nutr."},{"key":"10.1016\/j.cbi.2013.02.006_b0045","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clnu.2010.07.005","article-title":"Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes","volume":"30","author":"Tsai","year":"2011","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.cbi.2013.02.006_b0050","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3945\/jn.111.139824","article-title":"Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients","volume":"141","author":"Bonet","year":"2011","journal-title":"J. Nutr."},{"key":"10.1016\/j.cbi.2013.02.006_b0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3945\/ajcn.2008.26362","article-title":"Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects","volume":"89","author":"Greenfield","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cbi.2013.02.006_b0060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/diab.47.2.224","article-title":"Experimental NIDDM: development of a new model in rats administered streptozotocin and nicotinamide","volume":"47","author":"Masiello","year":"1998","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.cbi.2013.02.006_b0065","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2013.02.006_b0070","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2013.02.006_b0075","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejphar.2012.10.002","article-title":"Cycloart-23-ene-3\u03b2, 25-diol stimulates GLP-1 (7-36) amide secretion in streptozotocin\u2013nicotinamide induced diabetic Sprague Dawley rats: a mechanistic approach","volume":"698","author":"Badole","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2013.02.006_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0020700","article-title":"Resveratrol increases glucose Induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control","volume":"6","author":"Dao","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.cbi.2013.02.006_b0085","first-page":"665","article-title":"Gomori\u2019s aldehyde fuschin stain (special stain for \u03b2 cells)","volume":"20","author":"Gomori","year":"1950","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cbi.2013.02.006_b0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/bj1230805","article-title":"The stimulatory effects of carbon tetrachloride and other halogenoalkanes or peroxidative reactions in rat liver fractions in vitro","volume":"123","author":"Slater","year":"1971","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2013.02.006_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","article-title":"Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver","volume":"582","author":"Moron","year":"1979","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2013.02.006_b0100","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","article-title":"The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for SOD","volume":"247","author":"Misra","year":"1972","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.02.006_b0105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0076-6879(81)77053-8","article-title":"Assay of differentiation of glutathione S-transferases","volume":"77","author":"Habig","year":"1981","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cbi.2013.02.006_b0110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1126\/science.179.4073.588","article-title":"Selenium: biochemical role as a component of glutathione peroxidase","volume":"179","author":"Rotruck","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.cbi.2013.02.006_b0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with folin-phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2013.02.006_b0120","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.105.087064","article-title":"Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats","volume":"315","author":"Burkey","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.cbi.2013.02.006_b0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/en.2010-0956","article-title":"Glutamine triggers and potentiates glucagon-like peptide-1 secretion by raising cytosolic Ca2+ and cAMP","volume":"152","author":"Tolhurst","year":"2011","journal-title":"Endocrinol"},{"key":"10.1016\/j.cbi.2013.02.006_b0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/BF00405106","article-title":"Traditional plant treatments for diabetes: studies in normal and streptozotocin diabetic mice","volume":"33","author":"Swanston-Flat","year":"1990","journal-title":"Diabetol"},{"key":"10.1016\/j.cbi.2013.02.006_b0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bcp.2011.10.003","article-title":"A novel long acting DPP-IV inhibitor PKF-275-055 stimulates b-cell proliferation resulting in improved glucose homeostasis in diabetic rats","volume":"83","author":"Akarte","year":"2012","journal-title":"Biochim. Pharmacol."},{"key":"10.1016\/j.cbi.2013.02.006_b0245","author":"Bansal","year":"2011","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.cbi.2013.02.006_b0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1462-8902.2003.0310.x","article-title":"Lipoprotien abnormalities and their consequences for patients with type 2 diabetes","volume":"5","author":"Krentz","year":"2003","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cbi.2013.02.006_b0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cccn.2005.03.036","article-title":"Postprandial hypertriglyceridemia and oxidative stress in patients of type 2 diabetes mellitus with macrovascular complications","volume":"359","author":"Saxena","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cbi.2013.02.006_b0155","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0022-2275(20)38196-7","article-title":"Antidoxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity","volume":"30","author":"Morel","year":"1989","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cbi.2013.02.006_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0367-326X(02)00297-6","article-title":"Evaluation of antidiabetic effect of momordica cymbalaria fruit in alloxan-diabetic rats","volume":"74","author":"Apparao","year":"2003","journal-title":"Fitoterapia"},{"key":"10.1016\/j.cbi.2013.02.006_b0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1152\/ajpgi.00303.2004","article-title":"GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats","volume":"288","author":"Qin","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cbi.2013.02.006_b0170","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor (GLP-1R) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2013.02.006_b0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1152\/ajpgi.90635.2008","article-title":"GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate in rats","volume":"297","author":"Hira","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cbi.2013.02.006_b0180","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The glucagon-like peptides","volume":"20","author":"Kieffer","year":"1999","journal-title":"Endocrine Rev."},{"key":"10.1016\/j.cbi.2013.02.006_b0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.physbeh.2011.02.038","article-title":"Peripheral glucagon-like peptide-1 (GLP-1) and satiation","volume":"105","author":"Punjabi","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.cbi.2013.02.006_b0190","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/en.2004-0015","article-title":"Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system","volume":"145","author":"Brubaker","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2013.02.006_b0195","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-2004-826158","article-title":"On the physiology of GIP and GLP-1","volume":"36","author":"Holst","year":"2004","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cbi.2013.02.006_b0200","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1172\/JCI25764","article-title":"Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage","volume":"115","author":"Knauf","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2013.02.006_b0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2009.06.002","article-title":"Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors","volume":"124","author":"Verspohl","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2013.02.006_b0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/diabetes.53.1.5","article-title":"Epac: a new cAMP-binding protein in support of glucagon like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell","volume":"53","author":"Holz","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2013.02.006_b0215","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1113\/jphysiol.2006.119644","article-title":"Cell physiology of cAMP sensor","volume":"577","author":"Holz","year":"2006","journal-title":"Epac J. Physiol."},{"key":"10.1016\/j.cbi.2013.02.006_b0220","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3797\/scipharm.1104-16","article-title":"In vitro and in vivo effects of natural putative secretagogues of glucagon-like peptide-1 (GLP-1)","volume":"79","author":"Rafferty","year":"2011","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.cbi.2013.02.006_b0225","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00204-011-0774-2","article-title":"Antioxidant activity of food constituents-an overview","volume":"86","author":"Gulcin","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.cbi.2013.02.006_b0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0899-9007(01)00797-3","article-title":"Regulative potential of glutamine-relation to glutathione metabolism","volume":"18","author":"Roth","year":"2002","journal-title":"Nutrition"},{"key":"10.1016\/j.cbi.2013.02.006_b0235","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0026-0495(98)90357-2","article-title":"Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus","volume":"47","author":"De Mattia","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2013.02.006_b0240","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000658-199202000-00004","article-title":"Glutamine preserves liver glutathione after lethal hepatic injury","volume":"215","author":"Hong","year":"1992","journal-title":"Ann. Surg."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279713000409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279713000409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:29:23Z","timestamp":1757856563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279713000409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0009279713000409"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2013.02.006","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral l-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin\u2013nicotinamide induced diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2013.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}